• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素配体、受体与酶:药理学工具及治疗潜力

Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential.

作者信息

Hourani Wafa, Alexander Stephen P H

机构信息

School of Life Sciences, Medical School, University of Nottingham, Nottingham, UK.

出版信息

Brain Neurosci Adv. 2018 Jun 19;2:2398212818783908. doi: 10.1177/2398212818783908. eCollection 2018 Jan-Dec.

DOI:10.1177/2398212818783908
PMID:32166144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7058259/
Abstract

Endocannabinoids have been identified to have roles in numerous physiological and pathological processes. Largely due to the association of the effects of administration on mental states, the CNS impact of the endocannabinoid system has been the most intensively studied. Here, we provide a brief summary of the endocannabinoid system, comprising the receptors and the multiple endogenous lipid derivatives which activate them, as well as the enzymes which control the levels of these lipid derivatives. We identify pharmacological tools which may be used to interrogate the endocannabinoid system, as well as current and future options to exploit the system in the clinic.

摘要

内源性大麻素已被证实参与众多生理和病理过程。很大程度上由于其给药对精神状态的影响,内源性大麻素系统对中枢神经系统的影响得到了最为深入的研究。在此,我们对内源性大麻素系统进行简要概述,该系统包括受体、激活这些受体的多种内源性脂质衍生物,以及控制这些脂质衍生物水平的酶。我们还确定了可用于研究内源性大麻素系统的药理学工具,以及目前和未来在临床上利用该系统的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/7283ff087e18/10.1177_2398212818783908-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/bc1bcb4f421f/10.1177_2398212818783908-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/9db4e313c8d2/10.1177_2398212818783908-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/f52608753aa7/10.1177_2398212818783908-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/998c41d09df3/10.1177_2398212818783908-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/7283ff087e18/10.1177_2398212818783908-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/bc1bcb4f421f/10.1177_2398212818783908-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/9db4e313c8d2/10.1177_2398212818783908-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/f52608753aa7/10.1177_2398212818783908-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/998c41d09df3/10.1177_2398212818783908-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a308/7058259/7283ff087e18/10.1177_2398212818783908-fig5.jpg

相似文献

1
Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential.大麻素配体、受体与酶:药理学工具及治疗潜力
Brain Neurosci Adv. 2018 Jun 19;2:2398212818783908. doi: 10.1177/2398212818783908. eCollection 2018 Jan-Dec.
2
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.内源性大麻素系统调节意识水平、情绪及可能的梦境内容。
CNS Neurol Disord Drug Targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908.
3
The endocannabinoid system: physiology and pharmacology.内源性大麻素系统:生理学与药理学
Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. doi: 10.1093/alcalc/agh110. Epub 2004 Nov 18.
4
Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.大麻素类药物与内源性大麻素反应增强:针对多种疾病状态的策略
Curr Mol Med. 2006 Sep;6(6):677-84. doi: 10.2174/156652406778194991.
5
Role of lipids and lipid signaling in the development of cannabinoid tolerance.脂质及脂质信号传导在大麻素耐受性形成中的作用
Life Sci. 2005 Aug 19;77(14):1543-58. doi: 10.1016/j.lfs.2005.05.005.
6
From endocannabinoid profiling to 'endocannabinoid therapeutics'.从内源性大麻素分析到“内源性大麻素疗法”。
Curr Opin Chem Biol. 2009 Jun;13(3):321-31. doi: 10.1016/j.cbpa.2009.04.615. Epub 2009 Jun 3.
7
[The modulatory role of endocannabinoids in sleep].[内源性大麻素在睡眠中的调节作用]
Rev Neurol. 2008;46(3):160-6.
8
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol].[内源性大麻素受体配体——花生四烯乙醇胺和2-花生四烯酸甘油酯]
Yakugaku Zasshi. 2006 Feb;126(2):67-81. doi: 10.1248/yakushi.126.67.
9
[The role of endocannabinoid system in physiological and pathological processes in the eye].[内源性大麻素系统在眼部生理和病理过程中的作用]
Klin Oczna. 2008;110(10-12):392-6.
10
Therapeutic potential of cannabinoids in schizophrenia.大麻素在精神分裂症中的治疗潜力。
Recent Pat CNS Drug Discov. 2014 Apr;9(1):13-25. doi: 10.2174/1574889809666140307115532.

引用本文的文献

1
Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use - a review.植物大麻素和合成大麻素:从娱乐性消费到潜在治疗用途——综述
Front Toxicol. 2025 Jan 28;6:1495547. doi: 10.3389/ftox.2024.1495547. eCollection 2024.
2
The Anticancer Activity of Cannabinol (CBN) and Cannabigerol (CBG) on Acute Myeloid Leukemia Cells.大麻酚(CBN)和大麻二酚(CBG)对急性髓性白血病细胞的抗癌活性
Molecules. 2024 Dec 18;29(24):5970. doi: 10.3390/molecules29245970.
3
2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization.

本文引用的文献

1
Rationale for cannabis-based interventions in the opioid overdose crisis.在阿片类药物过量危机中使用大麻类药物干预的理由。
Harm Reduct J. 2017 Aug 18;14(1):58. doi: 10.1186/s12954-017-0183-9.
2
Cannabinoids in treatment-resistant epilepsy: A review.大麻素类药物在难治性癫痫治疗中的应用综述
Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8.
3
Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.合成大麻素的热解降解:化学暴露与药理后果
负载2-花生四烯酸甘油酯并靶向骨髓的聚己内酯纳米颗粒作为用于造血细胞系动员的纳米平台。
Stem Cell Res Ther. 2024 Oct 1;15(1):341. doi: 10.1186/s13287-024-03902-1.
4
Cannabinoids and the Gastrointestinal Tract.大麻素与胃肠道。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9.
5
Measuring white matter microstructure in 1,457 cannabis users and 1,441 controls: A systematic review of diffusion-weighted MRI studies.对1457名大麻使用者和1441名对照者的白质微观结构进行测量:扩散加权磁共振成像研究的系统综述。
Front Neuroimaging. 2023 Mar 7;2:1129587. doi: 10.3389/fnimg.2023.1129587. eCollection 2023.
6
The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy.地中海饮食作为具有类大麻素活性的生物活性分子的来源在预防和治疗策略中的应用。
Nutrients. 2022 Jan 21;14(3):468. doi: 10.3390/nu14030468.
7
The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System.早期接触大麻的影响:内源性大麻素系统的作用。
Int J Mol Sci. 2021 Aug 9;22(16):8576. doi: 10.3390/ijms22168576.
8
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.大麻素作为炎症小体信号的关键调节剂:当前视角。
Front Immunol. 2021 Jan 28;11:613613. doi: 10.3389/fimmu.2020.613613. eCollection 2020.
9
Effects of Cannabinoid Agonists and Antagonists on Sleep in Laboratory Animals.大麻素激动剂和拮抗剂对实验动物睡眠的影响。
Adv Exp Med Biol. 2021;1297:97-109. doi: 10.1007/978-3-030-61663-2_7.
10
Kaempferol Facilitated Extinction Learning in Contextual Fear Conditioned Rats via Inhibition of Fatty-Acid Amide Hydrolase.山奈酚通过抑制脂肪酸酰胺水解酶促进情境性恐惧条件大鼠的灭绝学习。
Molecules. 2020 Oct 14;25(20):4683. doi: 10.3390/molecules25204683.
J Pharmacol Exp Ther. 2017 Apr;361(1):162-171. doi: 10.1124/jpet.116.238717. Epub 2017 Jan 13.
4
"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.纽约发生的由合成大麻素 AMB-FUBINACA 引起的“僵尸”疫情。
N Engl J Med. 2017 Jan 19;376(3):235-242. doi: 10.1056/NEJMoa1610300. Epub 2016 Dec 14.
5
Cannabimimetic phytochemicals in the diet - an evolutionary link to food selection and metabolic stress adaptation?饮食中的类大麻素植物化学物质——与食物选择和代谢应激适应的进化联系?
Br J Pharmacol. 2017 Jun;174(11):1464-1483. doi: 10.1111/bph.13676. Epub 2017 Jan 16.
6
High-resolution crystal structure of the human CB1 cannabinoid receptor.人类CB1大麻素受体的高分辨率晶体结构。
Nature. 2016 Dec 22;540(7634):602-606. doi: 10.1038/nature20613. Epub 2016 Nov 16.
7
Crystal Structure of the Human Cannabinoid Receptor CB.人类大麻素受体CB的晶体结构
Cell. 2016 Oct 20;167(3):750-762.e14. doi: 10.1016/j.cell.2016.10.004.
8
The Endocannabinoid System as a Therapeutic Target in Glaucoma.内源性大麻素系统作为青光眼的治疗靶点
Neural Plast. 2016;2016:9364091. doi: 10.1155/2016/9364091. Epub 2016 Jan 12.
9
Allosteric Modulators: A Side Door.变构调节剂:旁门左道。
J Med Chem. 2016 Jan 14;59(1):42-3. doi: 10.1021/acs.jmedchem.5b01824. Epub 2015 Dec 8.
10
Therapeutic potential of cannabis-related drugs.大麻相关药物的治疗潜力。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:157-66. doi: 10.1016/j.pnpbp.2015.07.001. Epub 2015 Jul 26.